Chronic Blepharitis
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% (NCT02236403) | Universidad Nacional de Colombia | 2014-10-01 |
| Demodex Blepharitis Treatment Study (NCT01647217) | BioTissue Holdings, Inc | 2014-02-01 |
Track Chronic Blepharitis automatically
Every clearance here is in the API, with alerts when new ones post.